DAVID R SHAFFER MD NPI 1487625158

NPI Details

David R Shaffer, MD is a medical oncology internal medicine in Albany, NY. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. David R Shaffer, MD NPI is 1487625158. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

43 NEW SCOTLAND AVE
MAIL CODE 7
ALBANY, NY
ZIP 12208-412
Phone: (518) 262-6696

The NPI 1487625158 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Magnesium level (HCPCS:83735)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Testosterone (hormone) level, total (HCPCS:84403)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Unclassified drugs (HCPCS:J3490)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ferritin (blood protein) level (HCPCS:82728)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Ct scan of chest without contrast (HCPCS:71250)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)

The enumeration date for this NPI number is 1/30/2006 and was last updated on 3/20/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: